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Background: Blood products are an expensive and scarce resource with inherent risks to
patients. The current knowledge of rational blood product use among clinicians in South
Africa is unknown.
Purpose of research: To describe the level of clinicians' knowledge related to all aspects of the
ordering and administration of blood products from the South African Blood Services for
peri-operative patients at a tertiary hospital.
Method: A self-administered survey was distributed to 210 clinicians of different experience
levels from the departments of Anaesthesiology, General Surgery and Trauma, Orthopae-
dic Surgery and Obstetrics and Gynaecology at the study hospital. The questions related to
risks, cost, ordering procedures and transfusion triggers for red cell concentrate (RCC),
fresh frozen plasma (FFP) and platelets.
Results: A total of 172 (81.90%) surveys were returned. The overall mean for correctly
answered questions was 16.76 (±4.58). The breakdown by specialty was: Anaesthesiology
19.98 (±3.84), General Surgery and Trauma 16.28 (±4.05), Orthopaedic Surgery 13.83 (±4.17)
and Obstetrics and Gynaecology 15.63 (±3.51). Anaesthesiology performed better than other
disciplines (p < 0.001) and consultants out-performed their junior colleagues (p < 0.001).
Seventy percent correctly identified triggers for RCC transfusion and 50% for platelets.
Administration protocols were correctly defined by 80% for RCC and FFP just over 50% for
platelets. Thirty eight percent of respondents deemed infectious and non-infectious risk
sufficient to obtain informed consent. Knowledge of costs and ordering was below 30%.
Conclusion: Clinician's knowledge of risks, resources, costs and ordering of blood products
for perioperative patients is poor. Transfusion triggers and administration protocols had an
acceptable correct response rate.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of Johannesburg Uni-
versity. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).FFP, Fresh Frozen Plasma; SANBS, South African National Blood Service; ANOVA, Analysis of
wood, 2144, South Africa.
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Modernmedicine has a continued reliance on allogeneic blood
products. This is an expensive and scarce resource, with
inherent risks to patients. Escalating costs and declining
supplies have deepened the need to rationalise transfusion
practice. Several transfusion guidelines have been developed,
however, awareness and adherence to these guidelines seems
to be lacking as demonstrated in a number of surveys (Hebert
et al., 1998; Matot et al. 2004; Nutall, Stehling, Beighley, &
Faust, 2003; Stehling, Ellison, Faust, Grotta, & Moyers, 1987).
Between 5000 and 6000 blood products are ordered
monthly from the South African National Blood Service
(SANBS) at the study hospital and up to 30% of these orders are
cancelled or wasted (SANBS 2012).
In South Africa it is of paramount importance that medical
professionals have the competencies, skills and knowledge to
administer the limited and expensive blood products safely to
the most appropriate patients. There is no current literature
evaluating the level of knowledge of rational blood product
use in this country. The aim of this research was to describe
the level of clinicians' knowledge related to the ordering and
administration of blood products from the SANBS for periop-
erative patients at a tertiary hospital.
The primary objectives of the study were to determine the
knowledge of clinicians with regard to:
 risk associated with the transfusion of blood products,
 resources and costs associated with the transfusion of
blood products,
 donations, ordering and return of blood products,
 safe administration of blood products to a patient, and
 transfusion thresholds and triggers for blood product
administration.
The secondary objectiveswere to compare knowledge levels
among different specialty departments and clinician ranks.2. Method
A prospective, descriptive, contextual study design was used.
Ethics approval was obtained from the Human Research
Ethics Committee (Medical) (M120748) of the University of the
Witwatersrand and the other relevant authorities. The
research was conducted according to the principles of the
Declaration of Helsinki (2008).
The study hospital is a 2688 bed hospital where 65,000
surgeries are performed annually. The study population con-
sisted of clinicians working with perioperative patients in the
Anaesthesiology, General Surgery, Trauma, Orthopaedic Sur-
gery and Obstetrics and Gynaecology Departments belonging
to the professional ranks of intern, medical officer, registrar
and consultant. A purposive sampling method was used and
the sample size was realised by the number of respondents
who completed the questionnaire. The exclusion criteria of
the study were: clinicians who indicated that they have never been
involved in the administration of blood products at the
study hospital,
 who declined to take part in the study,
 who were on annual, special or sick leave and
 surveys that were less 50% complete.
A 20 question, self-administered, multiple-choice anony-
mous survey was drawn up based on a review of the literature
(Hebert et al., 1998; Irving, 1992; Matot et al. 2004; Nuttall et al.,
2003; Stehling et al. 1987; Turgeon et al. 2006; Vlaar, in der
Maur, Binnekade, Schultz, and Juffermans, 2009) and the
SANBS Clinical Guidelines for the use of blood products
ensuring content validity. Three senior anaesthesiologists and
a senior haematologist, all with blood product expertise,
reviewed the questionnaire ensuring face validity. Minor
changes were made based on recommendations given. The
adapted survey was given to 10 clinicians to assess for clarity.
No further suggestions were made.
The survey assessed the following:
 formal blood product education attendance,
 professional rank and department of clinicians,
 knowledge of risks of blood product administration,
 knowledge of resources and costs associated with the
transfusion of blood products,
 blood product donation, ordering and return administra-
tion of blood products according to the SANBS guideline,
and
 transfusion thresholds and triggers for blood product
administration.
The author (BY) addressed clinicians at departmental ac-
ademic meetings (January to March 2013), explaining the
study and inviting the clinicians to take part. The survey and
an information letter were distributed to willing respondents.
The completed surveys were collected at the meetings'
conclusion in a sealed box. Return of surveys implied consent
to take part in the study. The author (BY) was present during
the meetings to prevent data contamination and answer any
respondents' questions.
Data were analysed using descriptive and inferential sta-
tistics usingMicrosoft Excel forMac 2011 andGraphPad InStat.
For descriptive analysis of data that were normally distributed
mean and standard deviation (SD) were used. ANOVA testing
was used to compare means between groups. Bonferroni
testing and correction procedure was used for post-testing to
identify where the significant differences lie. A p-value < 0.05
was taken as statistically significant. Unanswered questions
were assumed to be the ‘don't know’ option at data capture.
No returned surveyswere discarded as all had beenmore than
half completed.3. Results
Therewere 210 surveys distributedwith 172 (81.90%) returned.
Demographics of respondents are demonstrated in Table 1.
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summarised in Table 2.
Of note, only 40e60% of respondents could quantify risk
and complications of transfusion and therefore obtain
informed consent. Knowledge of ordering processes and costs
was also poor with only 8% of respondents able to define a
crossmatch compared with type and screen.
RCC knowledge was more robust with 70e90% of re-
spondents able to identify triggers, physiological response and
appropriate temperatures for transfusion. A total of 123
(71.51%) respondents correctly responded to the haemoglobin
trigger question with 7 or 8 g/dl. These data are represented in
Fig. 1.
Similar questions regarding platelet administration were
answered correctly by less than 50% of respondents. FFP
knowledge seems haphazard.
The mean and standard deviation (SD) for correctly
answered questions was 16.76 (±4.58) from 32 questions for all
respondents as shown in Table 3. Specialty department
means were: Anaesthesiology 19.98 (±3.84), General Surgery
and Trauma 16.28 (±4.05), Orthopaedic Surgery 13.83 (±4.17)
and Obstetrics and Gynaecology 15.63 (±3.51). Clinician rank
means were: interns' 14.82 (±4.49), medical officers' 15.65
(±4.03), registrars' 17.0 (±4.34) and consultants' 20.09 (±3.67) as
shown in Table 4.
tatistical analysis did identify a significant difference be-
tween specialty departments with Anaesthesiology perform-
ing significantly better (p < 0.001) than the other departments.
No significant differences in performance were demonstrated
between General Surgery and Trauma, Orthopaedic Surgery
and Obstetrics and Gynaecology (p > 0.05).
A significant difference between clinician ranks was
shown. Consultants performed better than other ranks
(p < 0.005). Interns, medical officers and registrars performed
similarly with no significant difference between them
demonstrated (p > 0.005).
In the last two years formal education on blood products
had been attended by 34.30% of respondents. The annual
seminar (SANBS 2011) is the most likely setting for this
education.Table 1 e Completed questionnaire rate.





General surgery and trauma 36 (20.93%)
Orthopaedic surgery 40 (23.26%)






Medical officers 31 (18.02%)
Registrars 57 (33.14%)
Consultants 35 (20.35%)4. Discussion
The WHO launched a patient safety programme in 2008 with
the slogan of ‘Better knowledge for safer care’ (WHO Patient
Safety 2008). This programmeurges the prioritisation of patient
safety and identified inadequate competencies and skills as
well as the lack of appropriate knowledge and transfer of
knowledge among the top six research priorities in developed
and developing countries. These research priorities are specif-
ically appropriate for the transfusion of blood products, which
is a distinctive technology that blends science and altruism.
Various surveys have highlighted the variations in clinical
practice of blood product transfusion despite the multitude of
available guidelines (Hebert et al., 1998; Irving, 1992; Matot
et al. 2004; Nutall et al. 2003; Stehling et al. 1987). There is,
however a paucity in the literature with regard to describing
physicians' knowledge of risk, cost appropriate ordering,
administration, guidelines and physiology of blood product
transfusion. Knowledge of these aspects of blood product
transfusion is critical to ensure that the use of these scarce
resources are safe and cost-effective.
The safety of blood products, obtained from the SANBS,
appears to show parity with international standards and are
certainly the safest in sub-Saharan Africa (Jayaraman,
Chalabi, Perel, Guerriero, and Roberts, 2010; SANBS 2012;
SANBS 2009, SANBS 2008). However, risks are not completely
eliminated and clinicians' knowledge of the risks associated
with blood product administration appears to be poor with
only 38.37% of respondents able to accurately quantify both
the infectious and non-infectious risk. Just over half of the
respondents identified the most common cause of an adverse
reaction to blood product transfusion as clerical or laboratory
error and a similar number appreciated that blood product
administration is immunosuppressive. These findings are
similar to a South African survey published by Irving in 1992
where 30e60% of respondents were able to appropriately
quantify risks of blood product transfusion.
Poor awareness of costs was also demonstrated with
approximately half of all respondents overestimating costs of
FFP, underestimating costs of RCC and platelets and 73.84%
underestimating the cost of a crossmatch. If clinicians were
aware of the price of these products, for example, including
the price on the ordering form, or the availability of the SANBS
hamper system theymight bemore cognisant of only ordering
bloodwhen appropriate or use the hamper system if available.
A lack of understanding of the definitions and difference
between a crossmatch and a type and screen was poor with
only 48.26% defining a crossmatch correctly and 54.65%
defining a type and screen correctly. A concerning 29.65% and
16.28% of respondents indicated they did not know these
definitions at all. This may contribute to inappropriate
ordering of blood products. In 2011, 30% of blood products that
were ordered were not used at the study hospital (SANBS
2012).
It would seem that respondents' knowledge of RCC is better
than that of platelets and FFP with 97.67% of respondents
indicating an acceptable transfusion temperature, 71.51%
indicating an appropriate haemoglobin level transfusion
Table 2 e Results.
Question Answer Correct number (%)
Consent and risk Consent Verbal 54 (31.4%)
Infectious risk 0.001e1% 108 (62.79%)
Non-infectious risk 0.001e5% 83 (48.26%)
Reasons for complications Clerical 95 (55.23%)
Immunosuppression Yes 93 (54.07%)
Resources, cost, ordering and return RCC R1000-2000 50 (29.07%)
Platelets (pooled) R4500-6000 29 (16.86%)
Platelets (single donor) R6000-8000 51 (29.65%)
FFP R500-R1500 46 (26.74%)
Crossmatch R500-700 14 (8.14%)
Crossmatch description Blood matched 83 (48.26%)
Type and screen R100-300 52 (30.23%)
Type and screen description Blood group 94 (54.65%)
Donors Not remunerated 157 (91.28%)
MSBOS Aware 6 (3.49%)
Hamper awareness Aware 66 (38.37%)
Haemoglobin Trigger transfusion 7e8 g/dL 123 (71.51%)
One unit RCC raise 1e2 g/dL 156 (90.7%)
RCC temperature Cold/room/body 168 (97.67)
Platelets Prevent spontaneous bleed 10  109/L 41 (23.84%)
Raise platelet count 20e60  109/L 78 (45.35%)
Administration prior to procedure 50  109/L 82 (47.67%)
Platelet temperature Room 90 (52.33)
FFP Coagulopathy with bleeding Transfuse 150 (87.21%)
Abnormal lab test Not indicated 137 (79.65%)
Abnormal lab test prior to procedure Not indicated 71 (41.28%)
Severe burns Not indicated 52 (30.23%)
Massive transfusion Transfuse 152 (88.37%)
Volume expansion Not indicated 117 (68.02%)
Heparin reversal Not indicated 99 (57.56%)
Warfarin reversal Transfuse 126 (73.26%)
Correct dose 10e20 ml/kg 66 (38.37%)
FFP temperature Room/body 143 (83.14%)
Fig. 1 e Haemoglobin transfusion trigger.






Anaesthesiology 56 19.98 3.84
General surgery and trauma 36 16.28 4.05
Orthopaedic surgery 40 13.83 4.17
Obstetrics and gynaecology 40 15.63 3.51
Total 172 16.76 4.58
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would raise the haemoglobin by 1e2 g/dl. The trend of
accepting a lower haemoglobin, as in previous surveys, ap-
pears to be sustained and is reflected in this study while
platelet and FFP knowledge was not as robust in keeping with
other surveys (Hebert et al., 1998; Irving, 1992; Matot et al.
2004; Nuttall et al. 2003; Stehling et al. 1987). FFP knowledge
appears to be the weakest. Guidelines of FFP transfusion
triggers are very vague. Platelet trigger guidelines are morewell defined but used less often. This may contribute to these
results.
Attempts have beenmade to improve transfusion practices
of blood products. Verlicchi (2010) is of the opinion that pas-
sive distribution of recommendations and guidelines are
ineffective. Recently Joubert, Joubert, Raubenheimer, and
Louw (2014) conducted a follow up audit of red cell concen-
trate utilisation at a South African hospital. Their 2010 audit,
with subsequent interventions and training, seems to
demonstrate a sustained improvement in practice and
guideline adherence among clinicians in transfusing patients
with chronic anaemias. A series of publications (Louw,
2014a,b; Louw, Nel, & Hay, 2013a,b) discuss the status of
transfusion education in South Africa outlining international
challenges and local shortcomings. Again, the emphasis of





Interns 49 14.82 4.49
Medical officers 31 15.65 4.03
Registrars 57 17.0 4.34
Consultants 35 20.09 3.67
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education programme to educate leaders in the field. The re-
quirements of a formal education programmeare debated and
identified encompassing transfusion science, blood banking,
ethics, haematology and clinical transfusion medicine. The
differing education needs of specialists in transfusion medi-
cine compared with clinicians occasionally involved in
transfusion needs to be considered and implemented appro-
priately as these authors suggest. However, would the top-
down approach allow for a change in practice for the clini-
cians actually involved at the transfusion-patient interface?
In this study respondents fromAnaesthesiology performed
better than their colleagues although overall results remain
disappointing. Perhaps the better performance demonstrated
by Anaesthesiology respondents can be attributed to
observing a clinical response to administration of blood
products acutely with haemodynamicmonitoring. Among the
clinician ranks, consultants performed significantly better
than their junior colleagues. This is almost certainly due to
experience.
The study design was contextual at the study hospital in
selected disciplines and therefore the results may not be
generalizable to other hospitals and disciplines. As the study
was reliant on a self-administered survey it depended on the
integrity of respondents not giving socially acceptable an-
swers. The study also aimed to assess awareness of guide-
lines, however, awareness cannot be interpreted as adherence
to these guidelines.
Regular formal education on risk, resources, blood product
ordering and administration with appropriate feedback may
be of value and are recommended. Regular audits and feed-
back are also recommended. A review of the annual trans-
fusion summary is planned after discussion with the Local
Blood Committee and Hospital Management. Alternative ed-
ucation methods will also be discussed. Attaching informa-
tion on costs, definitions and risks to the SANBS ordering form
may be of benefit to clinicians and patients.
Blood products are a scarce resource with inherent risks.
Patient safety must be a priority. It is recommended that a
similar survey should be conducted nationally.5. Conclusion
Currently much emphasis is placed on patient safety,
furthermore escalating costs and a declining supply of blood
products require that clinicians rationalise their transfusion
practices. The results from this study has shown that clini-
cians' knowledge of risks, resources, costs, ordering and re-
turn of blood products is poor, especially regarding FFPadministration. Ensuring that clinicians have knowledge of
appropriate blood product use in perioperative patients can
make a meaningful contribution to patient safety and cost-
effective care.
The study has addressed a relevant and particular knowl-
edge deficit within the CHBAH and therefore is of value to the
SANBS, management of the institution and clinical
departments.
Research into reasons for the apparent poor knowledge
and whether guidelines are actually implemented should be
undertaken. Implementation and impact of any educational
intervention must be followed up. The blood product trans-
fusion seminar (SANBS 2011) is a potential area for
intervention.
This study was done in partial fulfilment of a Masters of
Medicine.
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